SNSE (Sensei Biotherapeutics, Inc. Common Stock) Stock Analysis - SEC Filings

Sensei Biotherapeutics, Inc. Common Stock (SNSE) is a publicly traded Healthcare sector company. As of May 21, 2026, SNSE trades at $17.58 with a market cap of $26.70M and a P/E ratio of -1.04. SNSE moved +4.59% today. Year to date, SNSE is +80.68%; over the trailing twelve months it is +167.91%. Its 52-week range spans $5.00 to $36.76. Rallies surfaces SNSE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find SNSE SEC filings?

Rallies organizes SNSE SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

SNSE Key Metrics

Key financial metrics for SNSE
MetricValue
Price$17.58
Market Cap$26.70M
P/E Ratio-1.04
EPS$-16.72
Dividend Yield0.00%
52-Week High$36.76
52-Week Low$5.00
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-21.09M
Gross Margin0.00%

Latest SNSE News

Recent SNSE Insider Trades

  • MILLENNIUM MANAGEMENT LLC bought 1.11K (~$36.99K) on Apr 7, 2026.
  • MILLENNIUM MANAGEMENT LLC sold 2.12K (~$61.21K) on Apr 7, 2026.
  • MILLENNIUM MANAGEMENT LLC sold 205 (~$6.09K) on Apr 7, 2026.

SNSE Analyst Consensus

SNSE analyst coverage data. Average price target: $0.00.

Common questions about SNSE

Where can I find SNSE SEC filings?
Rallies organizes SNSE SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show SNSE 10-K and 10-Q filings?
Rallies organizes SNSE SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is SNSE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SNSE. It does not provide personalized investment advice.
SNSE

SNSE